HOME >> MEDICINE >> NEWS
Dynavax Demonstrates Ability Of Immunostimulatory DNA Sequences To Inhibit Symptoms Of Allergic Asthma In Animal Model

BERKELEY, CA (December 15, 1998): Injections of proprietary immunostimulatory DNA sequences (ISS-DNA), under development by Dynavax Technologies Corporation, can alter the nature of the immune response in allergic asthma, while also inhibiting the symptoms of that disease, the company announced. Dynavax scientists and their collaborators published research in the December 15 issue of the Journal of Immunology showing that a single systemic or mucosal (intranasal or intratracheal) administration of ISS-DNA in an animal model of allergic asthma inhibited disease symptoms as effectively as systemic corticosteroids administered daily for seven days. Moreover, unlike the corticosteroids, ISS-DNA injections were able to redirect the immune response away from the strong Th2 response associated with allergic inflammation toward a non-allergic Th1 response.

"This study demonstrates in vivo, for the first time, that ISS-DNA can be used as a drug to both inhibit and modify allergic disease," said Dino Dina, M.D., president and chief executive officer of Dynavax. "In fact, our lead ISS-DNA molecule has proven active in every animal species that Dynavax scientists and their collaborators have tested to date, including primates. Based on their research, we believe that ISS-DNA therapy may provide a totally novel, highly effective therapy for chronic allergic pulmonary inflammation."

The Journal of Immunology study was authored by Dynavax founder, Eyal Raz, M.D. and David Broide, M.B. Ch.B. of the Department of Medicine, University of California, San Diego; and their collaborators Helen Tighe, Ph.D., Minh-Duc Nguyen, and Siamak Malek at Dynavax; Tim Gifford and John Van Uden at the University of California, San Diego; and Jurgen Schwarze, M.D. and Erwin W. Gelfand, M.D. at the Department of Pediatrics, National Jewish Medical and Research Center in Denver, CO.

In the study, the researchers used a mouse model of allergen-induced airway hyperresponsiveness to investi
'"/>

Contact: Joan Kureczka
jkureczka@aol.com
415-821-2413
Kureczka/Martin Associates
15-Dec-1998


Page: 1 2 3

Related medicine news :

1. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
2. New Report Demonstrates That Following Guidelines Improves Clinical Practices, Reduces Liability Costs
3. Study Demonstrates The Benefits Of Mammography In Women Under 50
4. Study Demonstrates Safety & Effectiveness Of Asthma Drug
5. Inhibitors prevent aggresome formation associated with some forms of ALS
6. Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice
7. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
8. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
9. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
10. Antabuse May Inhibit Fatal Reaction To Anesthetic
11. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... (PRWEB) , ... November 08, 2019 , ... ... the health care field, is pleased to announce that after the fourth quarter ... the 90th percentile with a 94.73% average pass rate. The College’s annual pass ...
(Date:11/7/2019)... (PRWEB) , ... November 06, 2019 , ... Atlantic Ultraviolet ... the flu is to get the flu shot. Since the flu season starts in ... Clinic in early Fall, where their employees can simply sign-up and get their shot. ...
(Date:11/7/2019)... ... November 07, 2019 , ... , Entomol’s safe and effective, EPA-approved all-natural ... includes a 4 and a 7 hour formulations. , “Entomol helps people live healthier ... Nile Virus and Encephalitis, without exposing them to the harmful chemicals found in other ...
(Date:11/7/2019)... ... November 07, 2019 , ... When Shamangelic Healing founder, ... together on the Shamangelic Healing Podcast to discuss techniques using quantum ... focus on learning ways to use bio-hacking to enhance a person’s body, productivity ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... University of Kentucky Research Foundation (UKRF) today announced they have entered into a ... hemp-derived product companies access to the broad resources of each organization to conduct ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... creating a buzz with its newly opened Adult Day Care Center on Pitkin ... social activities and wellness programs focused on managing and preventing diabetes. Seniors can ...
(Date:11/6/2019)... ... 06, 2019 , ... James M. Barthel, CEO of MT2 Firing Range Services ... their range lead into profit by giving the range owner/manager the highest value for ... the absolute highest value for their lead. No one reclaims more lead or pays ...
(Date:11/6/2019)... ... 2019 , ... Enara Health , a technology-powered clinical ... behaviors that are associated with higher weight loss in individuals enrolled in a ... study, “Mobile Engagement Behaviors Associated With Sustained 15% Weight Loss,” provides real-world evidence ...
Breaking Medicine Technology:
Cached News: